TRAVERE THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Other
TRAVERE THERAPEUTICS, INC. (TVTX) reported Adjustments to Additional Paid in Capital, Other of -$98.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2022-08-04
- TRAVERE THERAPEUTICS, INC. adjustments to additional paid in capital, other for the quarter ending 2021-06-30 was -$98.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month |
|---|---|
| 2021-06-30 | -$98.00K 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |